Critical Lym-1 binding residues on polymorphic HLA-DR molecules-Reference-Cited by-同舟云学术

Critical Lym-1 binding residues on polymorphic HLA-DR molecules

Published:1999-08 Issue:11-12 Volume:36 Page:789-797
ISSN:0161-5890
Container-title:Molecular Immunology
language:en
Short-container-title:Molecular Immunology

Author:

Rose L.M,Deng C.T,Scott S.L,Xiong C.Y,Lamborn K.R,Gumerlock P.H,DeNardo G.L,Meares C.F

Publisher

Elsevier BV

Subject

Molecular Biology,Immunology

Reference25 articles.

1. HLA-DR and -DQ serotyping;Brown,1993

2. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1;Brown;Nature,1993

3. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP);Bunce;Tissue Antigens,1995

4. Maximum-tolerated dose, toxicity, and efficacy of (131)I-Lym-1 antibody for fractionated radioimmunotherapy of non-Hodgkin’s lymphoma;DeNardo;Journal of Clinical Oncology,1998

5. The next generation of imaging and therapeutic agents for lymphoma and chronic lymphoytic leukemia;DeNardo;New Perspectives in Cancer Diagnosis and Management,1995

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In-Vivo Induced CAR-T Cell for the Potential Breakthrough to Overcome the Barriers of Current CAR-T Cell Therapy;Frontiers in Oncology;2022-02-10

2. The small molecule antibody mimic SH7139 targets a family of HLA-DRs expressed by B-cell lymphomas and other solid cancers;Journal of Drug Targeting;2020-07-02

3. A Humanized Lym-1 CAR with Novel DAP10/DAP12 Signaling Domains Demonstrates Reduced Tonic Signaling and Increased Antitumor Activity in B-Cell Lymphoma Models;Clinical Cancer Research;2020-04-09

4. High-Performance Concurrent Chemo-Immuno-Radiotherapy for the Treatment of Hematologic Cancer through Selective High-Affinity Ligand Antibody Mimic-Functionalized Doxorubicin-Encapsulated Nanoparticles;ACS Central Science;2018-12-26

5. Lym-1 Chimeric Antigen Receptor T Cells Exhibit Potent Anti-Tumor Effects against B-Cell Lymphoma;International Journal of Molecular Sciences;2017-12-20